InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: None

Tuesday, 02/27/2018 8:45:08 AM

Tuesday, February 27, 2018 8:45:08 AM

Post# of 14944
...IMHO...SRNE has a great opportunity through Celularity, but they seem to have shot itself in the foot...as reflected in today's announcement that "financials for 2017 should not be relied upon"...a huge no-no with institutions....

...a second "turn-down" tomorrow of drug review by FDA could cut this in half.

Seems like Celularity is it's ace in the hole ... but could get very rocky beginning today...and short term disastrous if FDA turn down tomorrow.

We shall see.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News